Aptilon Corp – Filings and Transcripts

OTC: APTOF
Share price (3/3/26): $1.59
Market cap (3/3/26): $317 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

ended 09/30/24 Q3

Prospectuses and Registrations Filter

Going private transaction – amended

Going private transaction – amended

Going private transaction – amended

Going private transaction

Removal from listing

Ownership Filter

Bleichroeder LP

Bleichroeder LP

Bleichroeder LP

Bleichroeder LP

Hanmi Pharmaceutical Co., Ltd.

News Filter

Aptose Biosciences Announces Amendment to Arrangement Agreement and Details of Postponed Special Meeting of Shareholders

Aptose Biosciences Announces Rescheduling of Special Meeting of Shareholders to Approve the Acquisition by Hanmi Pending Final Clearance From SEC

Aptose’s Tuspetinib Triple Drug Therapy Featured at the 2025 ASH Annual Meeting; High Rate of Frontline Clinical Responses Continues Across AML Populations

Material Definitive Agreement, Financial Statements or Exhibits

Aptose Biosciences Announces Arrangement Agreement for Acquisition by Hanmi Pharmaceutical

Proxies Filter

Proxy related to merger

Preliminary revised proxy

Preliminary revised proxy

Preliminary revised proxy

Preliminary proxy related to merger

Other Filter

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC